Home
|Insights
|The Long and Winding Road for BIOSIMILARS: Charting a Pathway through Patent, FDA, Antitrust, Prescription Filling, Reimbursement and Liability Law

PDF Link

The Long and Winding Road for BIOSIMILARS: Charting a Pathway through Patent, FDA, Antitrust, Prescription Filling, Reimbursement and Liability Law

Publication | 09.18.15

Contacts

Barbara H. Ryland
Senior Counsel
- Washington, D.C.
  - D | +1.202.624.2970
YnJ5bGFuZEBjcm93ZWxsLmNvbQ==

Insights

Publication | 09.24.25

Courts Keep Upping Standing Ante In ERISA Healthcare Suits

Publication | 09.22.25
Attorney General Bondi Issues New Guidance To Federal Agencies Concerning Its Interpretation Of “Unlawful Discrimination”
Publication | 09.22.25
Pemex Bribery Charges Provide Glimpse Into FCPA Evolution
Publication | 09.17.25
2026 Premiums To Increase For Covered California As Subsidies Expire

View All Insights

Subscribe

to the latest insights from our team